ImageneBio IMA
NASDAQ IMA
$4.07 -0.06 (-1.45%)
As of: Oct 21, 2026 · 12:09 PM EDT

ImageneBio (IMA) Change in Receivables (2020 - 2023)

Updated

Analysis

ImageneBio (IMA) Change in Receivables (2020 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,132.21 Bn 1,100.80 Bn 19.71 Bn -
2 Johnson & Johnson 616.27 Bn 534.80 Bn 17.26 Bn 1.35 Bn
3 AbbVie 500.10 Bn 473.21 Bn 12.70 Bn 1.37 Bn
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn -
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn -
6 Astrazeneca 261.53 Bn 235.22 Bn 12.86 Bn -
7 Amgen 234.99 Bn 190.39 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 190.14 Bn 164.34 Bn 6.22 Bn 333.00 Mn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn -
10 ImageneBio 34.70 Mn -452.92 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 754,000.00
Sep 30, 2023 632,000.00
Jun 30, 2023 356,000.00
Mar 31, 2023 345,000.00
Dec 31, 2022 338,000.00
Sep 30, 2022 331,000.00
Jun 30, 2022 316,000.00
Mar 31, 2022 307,000.00
Dec 31, 2021 300,000.00
Sep 30, 2021 296,000.00
Jun 30, 2021 55,000.00
Mar 31, 2021 89,000.00
Dec 31, 2020 275,000.00
Sep 30, 2020 268,000.00
Jun 30, 2020 267,000.00
Mar 31, 2020 168,000.00
API Access

ImageneBio Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=IMA&period=max&api_key=YOUR_API_KEY